effects of glp-1 Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds Adverse effects of GLP-1 class
Description
one-sided Fisher's exact test
Marso SP, Daniels GH, Poulter NR, et al
In rodents, stimulation of GLP-1 receptors in thyroid C cells promotes the secretion of calcitonin
While Merrill sees potential for the future of GLP-1 drugs to be helpful outside treating type 2 diabetes and obesity, he also understands the need for more studies
Two phase 2 trials are currently active but not recruiting: NCT04305002 evaluates weekly exenatide (2 mg) with disease progression measured by FDG-PET and MDS-UPDRS III, while NCT04269642 is investigating PT320, a sustained-release formulation of exenatide (2.0 or 2.5 mg biweekly), in patients with early PD
